Powder for reconstitution of the anti-HIV-1 drug TMC278 - Formulation development, stability and animal studies.
Van Gyseghem E, Pendela M, Baert L, Rosier J, Van 't Klooster G, De Man H, Bouche MP, Schueller L, Van Remoortere P, Wigerinck P, Adams E, Hoogmartens J, Van den Mooter G.
Van Gyseghem E, et al. Among authors: baert l.
Eur J Pharm Biopharm. 2008 Nov;70(3):853-60. doi: 10.1016/j.ejpb.2008.06.030. Epub 2008 Jul 9.
Eur J Pharm Biopharm. 2008.
PMID: 18657611